BAX
BAXTER INTERNATIONAL INC数据截止 2026 Q1(03-31)· 13F 季度快照
| 投资人 | 市值 | 占其组合 | 动作 |
|---|---|---|---|
| 丹·勒布Dan Loeb · Third Point | $3.4亿 | 4.7% | 大幅减仓 |
| 大卫·埃因霍恩David Einhorn · 绿光资本 Greenlight | $4924.1万 | 0.8% | 加仓 |
| 肯·格里芬Ken Griffin · Citadel 城堡投资PUT | $970.7万 | — | — |
| 伊兹·英格兰德Izzy Englander · 千禧管理 MillenniumCALL | $846.0万 | — | — |
| 肯·格里芬Ken Griffin · Citadel 城堡投资CALL | $653.0万 | — | — |
| 史蒂文·科恩Steven Cohen · Point72PUT | $501.0万 | — | — |
| 伊兹·英格兰德Izzy Englander · 千禧管理 MillenniumPUT | $384.2万 | — | — |
| 史蒂文·科恩Steven Cohen · Point72CALL | $330.0万 | — | — |
内部人交易
高管 / 董事 · Form 4Steven P. Wallace
President, Adv. Surgery
卖出$2,858153 股 @ $18.68交易 2026-06-02披露 2026-06-03James Teaff
President, CCS
卖出$5,996321 股 @ $18.68交易 2026-06-02披露 2026-06-03Anita A Zielinski
SVP, Interim CFO, CAO & Cntrlr
买入1 万股 @ $0.00交易 2026-06-01披露 2026-06-03David S. Wilkes
Director
买入1 万股 @ $0.00交易 2026-05-05披露 2026-05-07Patricia Morrison
Director
买入1 万股 @ $0.00交易 2026-05-05披露 2026-05-07David Brent Shafer
Director
买入1 万股 @ $0.00交易 2026-05-05披露 2026-05-07Michael R. Mcdonnell
Director
买入1 万股 @ $0.00交易 2026-05-05披露 2026-05-07Jeffrey A Craig
Director
买入1 万股 @ $0.00交易 2026-05-05披露 2026-05-07William A. Ampofo II
Director
买入1 万股 @ $0.00交易 2026-05-05披露 2026-05-07Amy Mcbride Wendell
Director
买入1 万股 @ $0.00交易 2026-05-05披露 2026-05-07Nancy M Schlichting
Director
买入1 万股 @ $0.00交易 2026-05-05披露 2026-05-07Joel T. Grade
EVP and CFO
卖出$14.4万8,153 股 @ $17.69交易 2026-03-06披露 2026-03-10Anita A Zielinski
SVP, CAO and Controller
卖出$3.4万1,932 股 @ $17.69交易 2026-03-06披露 2026-03-10Maria Cecilia Soriano
Group Pres., ITT & Pharma.
卖出$5.0万2,848 股 @ $17.69交易 2026-03-06披露 2026-03-10David S. Rosenbloom
EVP and General Counsel
卖出$11.7万6,620 股 @ $17.69交易 2026-03-06披露 2026-03-10Reazur Rasul
EVP,Group Pres,Healthcare
卖出$22.4万1 万股 @ $17.69交易 2026-03-06披露 2026-03-10Reazur Rasul
EVP,Group Pres,Healthcare
卖出$3.2万1,614 股 @ $19.69交易 2026-03-02披露 2026-03-03Andrew P. Hider
President and CEO
买入20 万股 @ $0.00交易 2026-02-27披露 2026-03-03Andrew P. Hider
President and CEO
买入49 万股 @ $20.37交易 2026-02-27披露 2026-03-03Cynthia Carlisle
Executive Vice President, CHRO
买入2 万股 @ $0.00交易 2026-02-27披露 2026-03-03Cynthia Carlisle
Executive Vice President, CHRO
买入1 万股 @ $0.00交易 2026-02-27披露 2026-03-03Cynthia Carlisle
Executive Vice President, CHRO
买入4 万股 @ $20.37交易 2026-02-27披露 2026-03-03Maria Cecilia Soriano
Group Pres., ITT & Pharma.
买入2 万股 @ $0.00交易 2026-02-27披露 2026-03-03Maria Cecilia Soriano
Group Pres., ITT & Pharma.
卖出$3.6万1,852 股 @ $19.69交易 2026-02-27披露 2026-03-03
内部人交易为公开 SEC Form 4 申报(公司高管、董事、10% 股东),仅供研究参考,非投资建议。
数据来自公开 SEC 13F 与 STOCK Act 申报,最长滞后约 45 天,仅含部分持仓,仅供研究、非投资建议。